NextAR Knee Platform 15.8020Recalls & reported problems
Medacta International SA · MyKnee NextAR TibPinPositioner_Ass-CT-GMK-RM · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07630345731661), received between Mar 30, 2026 and Mar 30, 2026 — classified as 1 malfunction.
The most frequently reported specific device problem is “Difficult or Delayed Positioning” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Difficult or Delayed Positioning1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 30, 2026Difficult or Delayed Positioning
DURING SURGERY, THE DISTAL FEMORAL CUT WAS REPORTED AS NOT STRAIGHT FORWARD, WITH AN INITIAL UNDER-RESECTION OF APPROXIMATELY 3D 4 MM COMPARED TO THE PLAN. ADDITIONAL CUTS WERE SUBSEQUENTLY PERFORMED; BOTH DISTAL AND POSTERIOR FEMORAL CUTS WERE ULTIMATELY ALIGNED WITH THE PREOPERATIVE PLANNING AND VERIFIED WITH A CALIPER. THE TIBIAL CUT WAS PERFORMED AS PLANNED. DESPITE THIS, POST-RESECTION ASSESSMENT REVEALED AN IMBALANCE IN BOTH FLEXION AND EXTENSION. WHEN USING THE PLANNED 10 MM POLYETHYLENE SPACER, THE SURGEON OBSERVED LAXITY IN BOTH PHASES, LEADING TO THE USE OF A 13 MM INSERT TO IMPROVE STABILITY. HOWEVER, WITH THE 13 MM TRIAL, THE KNEE BECAME TOO TIGHT IN EXTENSION WHILE REMAINING LAX IN FLEXION. A VALGUS RECUT WITH ADDITIONAL BONE RESECTION WAS THEN PERFORMED, ALTHOUGH NO MEASUREMENTS OF THE RESECTION DEPTH ARE AVAILABLE, AND THIS APPROACH APPEARS UNUSUAL GIVEN THE PRESENCE OF MEDIAL INSTABILITY. THE MEDIAL COMPARTMENT WAS REPORTED TO BE HIGHLY LAX, AS ALSO INDICATED BY NEXTAR. DUE TO PERSISTENT INSTABILITY AND PATIENT-RELATED FACTORS, A REVISION TIBIAL COMPONENT WITH WEDGES WAS IMPLANTED. THE OVERALL SURGICAL TIME INCREASED BY APPROXIMATELY 50 MINUTES. CASE CODE: (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24711334 ↗
Other Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices
- ATTUNE 1506-00-005Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER589 reports
- ATTUNE 1506-00-004Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER580 reports
- JOURNEY 74012812Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER502 reports
- JOURNEY 74011856Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER438 reports
- PERSONA™ 42-5099-094-00Zimmer, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER406 reports
- JOURNEY 74011857Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER388 reports
- ATTUNE 1506-00-007Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER288 reports
- ATTUNE 1506-00-003Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER271 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page